RecallRadar

FDA Drug recall D-0277-2019

children's allergy (cetirizine hydrochloride) Oral Solution, 1 mg/mL, ANTIHISTAMINE, Dye-Free, Sugar-Free, 4 FL OZ (120 mL) bottle, Distrib…

On 2018-11-21 the FDA classified a Class II recall of children's allergy (cetirizine hydrochloride) Oral Solution, 1 mg/mL, ANTIHISTAMINE, Dye-Free, Sugar-Free, 4 FL OZ (120 mL) bottle, Distrib… by Taro Pharmaceuticals U, citing failed Impurities/Degradation Specifications: unknown impurity higher than the specified limit was detected during routine stability testing.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0277-2019
ClassificationClass II
Statusterminated
Initiated2018-10-19
Published2018-11-21
Last updated2026-09-13 11:52 UTC
CompanyTaro Pharmaceuticals U
DistributionUS

Product

children's allergy (cetirizine hydrochloride) Oral Solution, 1 mg/mL, ANTIHISTAMINE, Dye-Free, Sugar-Free, 4 FL OZ (120 mL) bottle, Distributed by Publix Super Markets, Inc., 3300 Publix Corporate Parkway, Lakeland, FL 33811, NDC 56062-106-08, UPC 0 41415 43573 5.

Reason

Failed Impurities/Degradation Specifications: unknown impurity higher than the specified limit was detected during routine stability testing.

Identifiers

upc041415435735
ndc56062-106-08
code_infoLot # 313345, Exp 12/18

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0277-2019%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.